Clinical Report: Influence of Maternal Body Mass Index on Offspring Autism Risk
Overview
This cohort analysis from Sweden and Denmark investigates the relationship between maternal body mass index (BMI) during early pregnancy and the risk of autism spectrum disorder (ASD) in offspring. The study finds a continuous association between maternal BMI and ASD risk, highlighting the importance of considering BMI as a continuous variable rather than in categories.
Background
Autism spectrum disorder (ASD) is a growing concern, with prevalence rates exceeding 2% in children in the USA. Understanding the factors contributing to ASD is crucial for prevention and intervention strategies. Elevated maternal BMI has been suggested as a potential risk factor for ASD, necessitating further investigation into its impact on neurodevelopment.
Data Highlights
No specific numerical data provided in the source material.
Key Findings
The study utilized national health registers from Sweden and Denmark, covering live singleton births from 1998 to 2019 in Sweden and 2004 to 2018 in Denmark.
Maternal BMI was analyzed as a continuous variable, revealing a continuous association with ASD risk.
The association was examined for specificity by sex and for ASD with co-occurring intellectual disability (ID) and attention deficit hyperactivity disorder (ADHD).
A sibling comparison design was employed to assess the influence of unmeasured familial factors on ASD risk.
Previous studies have shown a weak level of evidence for the association between maternal obesity and ASD due to high heterogeneity.
Clinical Implications
Healthcare professionals should consider the implications of maternal BMI on offspring neurodevelopment when advising pregnant patients. Optimizing maternal weight before conception and during pregnancy may be crucial in reducing the risk of ASD in children.
Conclusion
This study underscores the importance of maternal BMI as a continuous variable in assessing ASD risk, suggesting that further research is needed to clarify the mechanisms involved and to inform clinical guidelines.
by Matilda Morin, Weiyao Yin, Heidi MacLean, Bernie Devlin, Abraham Reichenberg, Shanna H. Swan, Joseph D. Buxbaum, Diana Schendel, Martina Persson, Thomas Munk Laursen, Alexander Kolevzon, Jakob Grove, Lambertus Klei, Kathryn Roeder, Sven Sandin